Form 4: Bausch Health Director Amy Wechsler Boosts Stake

Bausch Health Companies Inc. Director Amy Wechsler acquired 989 common shares as restricted share units for board service, increasing her total beneficial ownership to 266,441 shares.

Summary

• Amy B. Wechsler, a Director of Bausch Health Companies Inc. (BHC), acquired 989 common shares.
• The transaction occurred on December 31, 2025, and was reported on January 2, 2026.
• The shares were acquired as Restricted Share Units (RSUs) in lieu of cash compensation for her service on the Issuer's Board of Directors for the quarter ending December 31, 2025.
• Each RSU represents a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.
• The acquisition price for these shares was $0, consistent with RSU grants.
• Following this transaction, Amy B. Wechsler beneficially owns a total of 266,441 common shares.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director increasing their stake, even through compensation, generally aligns their interests with shareholders. However, it's a routine compensation event, not a discretionary purchase, limiting its impact on overall sentiment.

Positives

• A director increasing their beneficial ownership, even through compensation, can signal continued alignment of interests with shareholders.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This is a routine insider transaction filing, common across all industries for directors and officers receiving equity compensation. It does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• The issuance of 989 Restricted Share Units to Director Amy B. Wechsler in lieu of cash compensation for her board service constitutes a related party transaction between the company and a member of its board.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership, even through compensation, can be viewed as a positive signal of continued commitment and alignment with shareholder interests.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director received equity compensation. While an increase in director ownership is generally positive for alignment, this specific transaction is not a discretionary purchase and does not provide new fundamental information about Bausch Health Companies Inc. to warrant a change in investment recommendation. Therefore, a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Bausch Health Companies Inc., BHC, Insider Transaction, Form 4, Director Compensation, Restricted Share Units, Equity Compensation, Rule 10b5-1